CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- 4 Open-market sale CFO and VP, Corp. Development sold 17,000 shares at $19.68 ($334,579)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale CFO and VP, Corp. Development sold 17,500 shares at an average $15.62 ($273,373)
- 4 Open-market sale CFO and VP, Corp. Development sold 17,500 shares at $17.02 ($297,859)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 7,500 shares at $16.81 ($126,095)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CFO and VP, Corp. Development sold 15,625 shares at an average $17.64 ($275,592)
- 4 Open-market sale CFO and VP, Corp. Development sold 10,000 shares at $20.02 ($200,235)
- 4 Open-market sale Director sold 7,500 shares at $18.02 ($135,129)
- 4 Option exercise President and CEO acquired 36,192 shares (option exercise)
- 4 Open-market sale CFO and VP, Corp. Development sold 10,000 shares at $17.09 ($170,880)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
- 4 Option exercise Director acquired 17,500 shares (option exercise)
Page 17 of 32 · 637 filings